澳门老奇人论坛

Meeting Coverage >

CROI

Severe Mpox in Advanced HIV Patients Tied to Complications, Death

Researchers argue that severe mpox is AIDS-defining; critics say that's stigmatizing

Higher Dose of Ivermectin, and for Longer, Still No Help Against COVID

Losing streak continues for controversial antiparasitic

Children's HIV Deaths in Africa Largely Preventable

Half of kids under age 5 not diagnosed before death, CHAMPS study found

Investigational Oral Antiviral Shows Promise in COVID Outpatients

Exploratory analyses also point to possible reduction in long COVID symptoms

COVID Rebound Not Exclusive to Those on Paxlovid

However, these rebound cases were rare and lasted only about 1 day

Large Benefit With Long-Acting PrEP in Black People, but Some HIV Risk Persists

Substudy of HPTN 083 trial examined differences in outcomes by race among U.S. participants

Doxycycline Fails to Protect Women Against STIs

Trial results came as a surprise after success in prophylaxis for other groups

Sutezolid With 3-Drug Combo Appears Safe and Effective in Multidrug-Resistant TB

Sutezolid may be a replacement for linezolid in these patients, researcher says

TB Treatment Strategy Has Potential to Drastically Slash Therapy Duration

8-week regimen, with more for persistent cases, yields similar outcomes to 6-month standard

HIV Self-Tests Reached High-Risk Populations

CDC researchers found a substantial minority of patients had never been tested

Ablating High-Grade Anal Lesions Thwarts Progression to Cancer

Screening followed by aggressive therapy shows benefit in phase III ANCHOR study

Injectable Sotrovimab Offers Another Route for COVID Treatment

Intramuscular version of monoclonal antibody on par with infusion

COVID Makes Everything Worse in Pregnancy

And those with HIV experienced the worst outcomes

Young Women Prefer Vaginal Ring as HIV Prevention

But oral pre-exposure prophylaxis also gets support, study in Africa finds

Fewer Pills Plus Shorter Time: New Way to Control Drug-Resistant TB?

Randomized trial looks at three investigational regimens versus standard of care

Universal HCV Screening in Pregnancy Boosts Detection

More cases found verses risk-based approach, also IDs perinatal transmission, researcher says

ART-Free Strategy Could Control HIV in Some African Kids

Broadly neutralizing antibodies show promise in proof-of-concept study in Botswana

Third Person 'Cured' of HIV via Transplant

U.S. woman with leukemia gets cord blood resistant to HIV

Novel Strategy Slashes HBV Vertical Transmission Sans Immunoglobulin

Cambodian study finds antenatal antiviral effective if used for long enough

U.S. Sees Drop in Lifetime Risk of HIV Diagnosis

One of every 120 Americans will be diagnosed with HIV in their lifetime, analysis suggests

Healers Lend a Hand to HIV Testing in Rural Uganda

Modern medicine benefits from engaging with local traditions

Could One mRNA COVID Shot Be Adequate for Past Infectees?

Small study shows powerful antibody response after first dose

Novel Drug Dents Super-Refractory HIV Infection

"I was blown away by these results," said press conference moderator

Therapeutic HIV Vax Trial Takes Its First-in-Human Steps

But long way from a true functional cure

Pediatric HIV: Trial Sets Tivicay Backbone as Best First-Line Option

And "at least non-inferior" in second line

HIV, High-Risk Pregnancy and Coronavirus

Outcomes support case for pregnant women to be vaccinated against COVID-19

Maturation Inhibitor Shows Promise for HIV

Encouragement from phase II study, but emergent resistance remains a problem

Do HIV Drug Trials Need Better Infection Tests?

Data from PrEP study reveal a sensitivity problem

Dramatic Increase Seen in Getting HIV Patients Into Treatment

Percentage of newly diagnosed individuals receiving "timely" therapy doubled in past decade

'Amazon Prime'-Type ART Delivery Worked for South African HIV Patients

More experienced viral suppression versus traditional clinic visits

PrEP Implant May Protect Against HIV for a Year

Early study paves way for clinical trial

Good News, Bad News in HIV Prevention Research

HVTN vaccine trial failed, but phase I antibody trial showed promise

HIV+ Adults Living Longer, but Not Healthier Lives

Fewer comorbidity-free years versus those without HIV, even among those starting ART early

Attack on HIV Reservoir Falls Short

No impact seen with romidepsin and neutralizing antibody agent

Birth Control Implants, HIV Meds Safe Together

Drug-drug interactions not seen in combination

West Virginia HIV Outbreak: A Blueprint for Public Health Response

Used four pillars of federal initiative to manage local HIV epidemic

After 30 Months, 'London Patient' Still in HIV Remission

Longer-term findings encouraging in blood, semen, and other HIV reservoir sites

What's Behind London's Falling HCV Rates in HIV+ MSM?

City cut HCV incidence in this population by almost 70% in 5 years

Monthly HIV Treatment on Par With Daily Regimen

High percentage of patients maintain undetectable viral loads

Integrase Inhibitors Drop Virus Faster in Pregnant HIV Patients

Raltegravir, dolutegravir both appear safe and effective in late stage pregnancy

1